Literature DB >> 16087285

Medical aspects of toxin weapons.

Hans Bigalke1, Andreas Rummel.   

Abstract

For centuries, poisons and other biological material have been considered as weapons. However, it has been merely 100 years that the use of biological toxins as weapons has been explored scientifically. Trichothecenes, ricin and botulinum neurotoxins are natural organic toxins with diverse potencies. Their molecular structure, mechanisms of action, detection, clinical diagnosis and therapy are reviewed and their potential as biological weapon is discussed. It is not only the median lethal dose of each toxin that decides on its usability as a biological weapon, but also the availability, scale of production, purity of the isolated material and route of distribution. In general, without a state infrastructure, the use of biological weapons is restricted to assassinations or strictly localised terrorist attacks.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16087285     DOI: 10.1016/j.tox.2005.06.015

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  24 in total

1.  Molecular basis of activation of endopeptidase activity of botulinum neurotoxin type E.

Authors:  Roshan V Kukreja; Shashi K Sharma; Bal Ram Singh
Journal:  Biochemistry       Date:  2010-03-23       Impact factor: 3.162

Review 2.  Botulinum neurotoxin - from laboratory to bedside.

Authors:  K A Foster; H Bigalke; K R Aoki
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

3.  High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.

Authors:  Matthew J Saunders; Steven W Graves; Larry A Sklar; Tudor I Oprea; Bruce S Edwards
Journal:  Assay Drug Dev Technol       Date:  2010-02       Impact factor: 1.738

4.  Development of an ELISA microarray assay for the sensitive and simultaneous detection of ten biodefense toxins.

Authors:  Kathryn L Jenko; Yanfeng Zhang; Yulia Kostenko; Yongfeng Fan; Consuelo Garcia-Rodriguez; Jianlong Lou; James D Marks; Susan M Varnum
Journal:  Analyst       Date:  2014-08-12       Impact factor: 4.616

5.  Comparison of oral toxicological properties of botulinum neurotoxin serotypes A and B.

Authors:  Luisa W Cheng; Thomas D Henderson
Journal:  Toxicon       Date:  2011-05-11       Impact factor: 3.033

6.  Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors.

Authors:  Bing Li; Steven C Cardinale; Michelle M Butler; Ramdas Pai; Jonathan E Nuss; Norton P Peet; Sina Bavari; Terry L Bowlin
Journal:  Bioorg Med Chem       Date:  2011-10-26       Impact factor: 3.641

Review 7.  Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin.

Authors:  Kwok-Ho Lam; Guorui Yao; Rongsheng Jin
Journal:  Prog Biophys Mol Biol       Date:  2015-02-19       Impact factor: 3.667

8.  Crystallization and preliminary X-ray diffraction data analysis of stenodactylin, a highly toxic type 2 ribosome-inactivating protein from Adenia stenodactyla.

Authors:  Giovanna Tosi; Simona Fermani; Giuseppe Falini; Letizia Polito; Massimo Bortolotti; Andrea Bolognesi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-12-25

9.  Detection of ricin intoxication in mice using serum peptide profiling by MALDI-TOF/MS.

Authors:  Siyan Zhao; Wen-Sen Liu; Meng Wang; Jiping Li; Yucheng Sun; Nan Li; Feng Hou; Jia-Yu Wan; Zhongyi Li; Jun Qian; Linna Liu
Journal:  Int J Mol Sci       Date:  2012-10-22       Impact factor: 5.923

10.  Detection of botulinum neurotoxin serotypes A and B using a chemiluminescent versus electrochemiluminescent immunoassay in food and serum.

Authors:  Luisa W Cheng; Larry H Stanker
Journal:  J Agric Food Chem       Date:  2013-01-10       Impact factor: 5.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.